RAPID DISPATCH
24/H dispatch
5 in stock
RRS HA STRIMATRIX is an intradermal implant containing reabsorbable, non-crosslinked hyaluronic acid, combined with a bio-revitalising solution, specifically formulated for skin affected by stretch marks and skin laxity.
USE MEDICAL STRICT. Medical device. Use reserved for dermatologists and aesthetic doctors because they require a medical procedure.
RRS HA STRIMATRIX is an injectable implant:
- Of non-animal biotechnological origin.
- Enriched with a bio-revitalising complex.
- Promotes regeneration of the dermal matrix and improvement of atrophic skin depressions.
- Stimulates fibroblastic activity and the production of collagen and elastin.
- SKIN TECH PHARMA GROUP S.L.U.
- NAME: RRS HA STRIMATRIX
- COMPOSITION: 2 mg/ml hyaluronic acid, 1 fibroblast growth factor (FGF), 1 sodium DNA, 14 amino acids, 9 trace elements, 8 antioxidants, 7 vitamins, 2 fatty acids, 2 coenzymes, 2 flavonoids, 2 saponins, 2 triterpenes.
- PRESENTATION: 6 x 10 ml.
- INDICATIONS: Treatment of structural changes in the skin characterised by loss of elasticity and dermal atrophy.
- INJECTION DEPTH: Superficial dermis, using the technique of longitudinal superficial micro-injections in retro-tracking.
- DURATION: For optimal results, 4-6 initial treatments are recommended. Sessions with RRS HA Strimatrix are scheduled weekly. To maintain the effect over time, maintenance treatments can be carried out every 4 months.
- USE: Strict medical use.
- Vials: 6 x 10 ml.
Abdomen, buttocks, inner arms, inner thighs, arms and shoulders.
2 mg/ml hyaluronic acid, 1 fibroblast growth factor (FGF), 1 sodium DNA, 14 amino acids, 9 trace elements, 8 antioxidants, 7 vitamins, 2 fatty acids, 2 coenzymes, 2 flavonoids, 2 saponins, 2 triterpenes.
- The product should only be used by a doctor or qualified healthcare personnel experienced in intradermal injection techniques.
- Strictly apply aseptic technique to reduce the risk of local infection.
- Do not use the product if the packaging is opened, damaged or past its expiry date.
- The device is for single use only: do not re-use or attempt re-sterilisation.
- Inject superficially into the dermis according to recommended techniques (e.g. microinjections or superficial retrotracers).
- Inform the patient of the possible transient appearance of redness, oedema, swelling or small haematomas at the injection site.
- After treatment, avoid intense sun exposure, UV lamps, saunas, steam baths and intense physical activity for at least 24-48 hours.
- Use caution in patients with an allergic history or particularly sensitive skin.
RRS HA STRIMATRIX is contraindicated in the following cases:
- Known or suspected hypersensitivity to any of the components of the formulation.
- Active skin infection, inflammation, dermatitis or open lesions at the injection site.
- Active autoimmune diseases or conditions that significantly alter the immune response.
- Pregnancy and lactation, in the absence of sufficient clinical safety data.
- Ongoing neoplasms or recent history of oncological pathologies, unless otherwise assessed by a doctor.
- Patients with uncontrolled coagulation disorders or inadequately managed anticoagulation therapy.
- Patients under 18 years of age.
RRS HA STRIMATRIX is specifically indicated for filling and, at the same time, the action of the implant is supported by the regeneration of the dermal matrix of atrophic skin depressions, such as stretch marks and skin laxity.
It is an intradermal biorevitalising implant designed to treat stretch marks, skin atrophies and loss of skin elasticity by stimulating dermal regeneration.
It acts by stimulating fibroblastic activity and the production of collagen and elastin, improving the quality, firmness and elasticity of the skin thanks to the combination of hyaluronic acid and bio-revitalising complexes.
Four to six initial sessions are generally carried out weekly, with possible maintenance treatments every four months to maintain the results obtained.
It is mainly indicated for the abdomen, buttocks, inner arms, inner thighs, shoulders and other areas affected by stretch marks or skin laxity.
Treatment must only be performed by qualified medical or healthcare personnel using intradermal microinjection techniques in a sterile environment.